Polio endemic nations hit all-time low

27 February 2006

The number of countries with indigenous polio has dropped to an all-time low of four, as disease eradication efforts enter a new phase involving the use of next-generation vaccines targeted at the two surviving strains of virus, according to the World Health Organization. In 2006, monovalent vaccines, aimed at individual virus strains, will be the primary platform for eradication of all remaining polio-affected areas, announced the core partners in the project, including the WHO, Rotary International and the US Centers for Disease Control and Prevention.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight